Geulah Livshits
Stock Analyst at Chardan Capital
(1.85)
# 3,027
Out of 4,840 analysts
200
Total ratings
28.87%
Success rate
-9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Maintains: Buy | $16 → $12 | $1.27 | +844.88% | 5 | May 19, 2025 | |
| SLDB Solid Biosciences | Maintains: Buy | $16 → $15 | $3.04 | +393.42% | 7 | May 19, 2025 | |
| IPSC Century Therapeutics | Maintains: Buy | $7 → $6 | $0.56 | +968.38% | 6 | May 16, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $45 → $46 | $2.33 | +1,874.25% | 17 | May 16, 2025 | |
| MGX Metagenomi | Maintains: Buy | $13 → $12 | $1.66 | +622.89% | 6 | May 15, 2025 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $22 → $20 | $2.70 | +640.74% | 9 | May 13, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $28 → $25 | $3.42 | +630.99% | 9 | May 9, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $30 → $25 | $1.73 | +1,345.09% | 12 | May 9, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $68 | $9.33 | +629.22% | 14 | May 9, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Buy | $9 | $0.45 | +1,883.25% | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 | $126.45 | +73.19% | 10 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $82 | $37.57 | +118.26% | 13 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 | $1.64 | +692.68% | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $3.31 | +262.54% | 8 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $23.92 | +109.03% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $0.36 | +1,575.51% | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $2.61 | +168.71% | 12 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.15 | - | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.65 | - | 10 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $5.09 | +706.29% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $4.93 | +407.10% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.74 | +589.66% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $26.76 | +677.28% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $1.43 | +1,018.88% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $2.5 | $8.16 | -69.36% | 5 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $9.07 | +892.28% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $2.82 | +41.84% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $30 | $2.27 | +1,221.59% | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $8.60 | +109.30% | 1 | Oct 27, 2020 |
Prime Medicine
May 19, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $1.27
Upside: +844.88%
Solid Biosciences
May 19, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $3.04
Upside: +393.42%
Century Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $0.56
Upside: +968.38%
Rocket Pharmaceuticals
May 16, 2025
Maintains: Buy
Price Target: $45 → $46
Current: $2.33
Upside: +1,874.25%
Metagenomi
May 15, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $1.66
Upside: +622.89%
Lexeo Therapeutics
May 13, 2025
Maintains: Buy
Price Target: $22 → $20
Current: $2.70
Upside: +640.74%
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $28 → $25
Current: $3.42
Upside: +630.99%
Iovance Biotherapeutics
May 9, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $1.73
Upside: +1,345.09%
Intellia Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $68
Current: $9.33
Upside: +629.22%
Tenaya Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $9
Current: $0.45
Upside: +1,883.25%
May 7, 2025
Maintains: Buy
Price Target: $219
Current: $126.45
Upside: +73.19%
May 7, 2025
Maintains: Buy
Price Target: $84 → $82
Current: $37.57
Upside: +118.26%
May 6, 2025
Maintains: Buy
Price Target: $13
Current: $1.64
Upside: +692.68%
May 2, 2025
Maintains: Buy
Price Target: $12
Current: $3.31
Upside: +262.54%
Apr 9, 2025
Initiates: Buy
Price Target: $50
Current: $23.92
Upside: +109.03%
Mar 4, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $0.36
Upside: +1,575.51%
Feb 26, 2025
Maintains: Buy
Price Target: $7
Current: $2.61
Upside: +168.71%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.15
Upside: -
Dec 13, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.65
Upside: -
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $5.09
Upside: +706.29%
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $4.93
Upside: +407.10%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $1.74
Upside: +589.66%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $26.76
Upside: +677.28%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $1.43
Upside: +1,018.88%
Aug 22, 2022
Maintains: Buy
Price Target: $4 → $2.5
Current: $8.16
Upside: -69.36%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $9.07
Upside: +892.28%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $2.82
Upside: +41.84%
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $2.27
Upside: +1,221.59%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $8.60
Upside: +109.30%